Targets — browse / sort / filter (view)
Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target
- id
- UniProt accession (human). Links to uniprot.org.
- gene_symbol
- Gene symbol (e.g. ITGB3).
- protein_name
- Protein name (UniProt).
- tier
- Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
- has_structure
- 1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
- evidence_priority
- DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
- has_activation_state_pdb_pair
- 1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
- in_cev_map
- Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
- has_known_aptamer
- 1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
- opentargets_top_disease_score
- Open Targets association score (0-1).
- aptamer_count_pubmed
- Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
- aptamer_pmids
- The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
- surface_class
- PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.
171 rows where has_known_aptamer = 0, in_cev_map = 0 and surface_class = "A_assoc" sorted by evidence_priority descending
This data as json, CSV (advanced)
Suggested facets: pdb_count_total
surface_class 1
- A_assoc · 171 ✖
in_cev_map 1
- - · 171 ✖
has_known_aptamer 1
- - · 171 ✖
has_activation_state_pdb_pair 1
- 0 171
| id | gene_symbol | protein_name | tier | evidence_priority ▲ | has_structure | surface_class | pdb_count_total | alphafold_mean_pLDDT | has_cryoEM | has_activation_state_pdb_pair | activation_state_pdb_active | activation_state_pdb_inactive | has_known_aptamer | aptamer_count_pubmed | aptamer_pmids | in_cev_map | opentargets_top_disease_name | opentargets_top_disease_score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Q9NZK5 | ADA2 | Adenosine deaminase 2 | Tier 1 | 0.699 | 1 | A_assoc | 2 | 95.81 | 0 | 0 | 0 | 0 | 0 | deficiency of adenosine deaminase 2 | 0.8291292532404531 | |||
| Q99972 | MYOC | Myocilin | Tier 1 | 0.699 | 1 | A_assoc | 24 | 78.94 | 0 | 0 | 0 | 0 | 0 | glaucoma 1, open angle, A | 0.8294483747483756 | |||
| O95970 | LGI1 | Leucine-rich glioma-inactivated protein 1 | Tier 1.5 | 0.697 | 1 | A_assoc | 9 | 92.56 | 1 | 0 | 0 | 0 | 0 | autosomal dominant epilepsy with auditory features | 0.8225657483127345 | |||
| Q9UBH0 | IL36RN | Interleukin-36 receptor antagonist protein | Tier 1 | 0.695 | 1 | A_assoc | 3 | 92.44 | 0 | 0 | 0 | 0 | 0 | psoriasis 14, pustular | 0.8155144873787125 | |||
| Q96MK3 | FAM20A | Pseudokinase FAM20A | Tier 1 | 0.693 | 1 | A_assoc | 4 | 85.25 | 0 | 0 | 0 | 0 | 0 | amelogenesis imperfecta type 1G | 0.8106031517056754 | |||
| P55000 | SLURP1 | Secreted Ly-6/uPAR-related protein 1 | Tier 1 | 0.692 | 1 | A_assoc | 2 | 84.19 | 0 | 0 | 0 | 0 | 0 | mal de Meleda | 0.8064330379723671 | |||
| P29460 | IL12B | Interleukin-12 subunit beta | Tier 1 | 0.687 | 1 | A_assoc | 20 | 91.12 | 1 | 0 | 0 | 0 | 0 | psoriasis | 0.7914863943708039 | |||
| P29120 | PCSK1 | Neuroendocrine convertase 1 | Tier 1.5 | 0.682 | 1 | A_assoc | 3 | 82.5 | 0 | 0 | 0 | 0 | 0 | obesity due to prohormone convertase I deficiency | 0.773875795833803 | |||
| P20849 | COL9A1 | Collagen alpha-1(IX) chain | Tier 1 | 0.678 | 1 | A_assoc | 5 | 61.5 | 0 | 0 | 0 | 0 | 0 | Stickler syndrome | 0.7594904923903256 | |||
| P16112 | ACAN | Aggrecan core protein | Tier 1.5 | 0.677 | 1 | A_assoc | 4 | 51.91 | 0 | 0 | 0 | 0 | 0 | Familial osteochondritis dissecans | 0.7558487616449627 | |||
| P55789 | GFER | FAD-linked sulfhydryl oxidase ALR | Tier 1.5 | 0.677 | 1 | A_assoc | 7 | 76.88 | 0 | 0 | 0 | 0 | 0 | congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome | 0.7556346526616893 | |||
| Q12794 | HYAL1 | Hyaluronidase-1 | Tier 1.5 | 0.672 | 1 | A_assoc | 1 | 94.0 | 0 | 0 | 0 | 0 | 0 | Hyaluronidase deficiency | 0.7412407206736383 | |||
| Q92752 | TNR | Tenascin-R | Tier 1.5 | 0.672 | 1 | A_assoc | 2 | 78.5 | 0 | 0 | 0 | 0 | 0 | neurodevelopmental disorder, nonprogressive, with spasticity and transient opisthotonus | 0.7403484347367364 | |||
| Q2MKA7 | RSPO1 | R-spondin-1 | Tier 1 | 0.669 | 1 | A_assoc | 12 | 74.69 | 1 | 0 | 0 | 0 | 0 | palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome | 0.7285342885472184 | |||
| P12272 | PTHLH | Parathyroid hormone-related protein | Tier 1 | 0.666 | 1 | A_assoc | 11 | 62.88 | 1 | 0 | 0 | 0 | 0 | brachydactyly type E | 0.7203484375635054 | |||
| Q99574 | SERPINI1 | Neuroserpin | Tier 1 | 0.665 | 1 | A_assoc | 3 | 88.12 | 0 | 0 | 0 | 0 | 0 | familial encephalopathy with neuroserpin inclusion bodies | 0.7162803151916303 | |||
| P11686 | SFTPC | Surfactant protein C | Tier 1.5 | 0.663 | 1 | A_assoc | 3 | 70.06 | 0 | 0 | 0 | 0 | 0 | Congenital pulmonary alveolar proteinosis | 0.7110128683619542 | |||
| O43897 | TLL1 | Tier 1.5 | 0.662 | 1 | A_assoc | 1 | 80.31 | 0 | 0 | 0 | 0 | 0 | atrial heart septal defect | 0.7050140477090344 | ||||
| P27352 | CBLIF | Cobalamin binding intrinsic factor | Tier 1.5 | 0.655 | 1 | A_assoc | 2 | 90.5 | 0 | 0 | 0 | 0 | 0 | hereditary intrinsic factor deficiency | 0.683930100359911 | |||
| Q8N300 | SVBP | Small vasohibin-binding protein | Tier 1 | 0.649 | 1 | A_assoc | 24 | 85.06 | 1 | 0 | 0 | 0 | 0 | neurodevelopmental disorder with ataxia, hypotonia, and microcephaly | 0.6640118055835142 | |||
| O95631 | NTN1 | Netrin-1 | Tier 1.5 | 0.648 | 1 | A_assoc | 5 | 88.5 | 1 | 0 | 0 | 0 | 0 | mirror movements 4 | 0.6611393488240481 | |||
| Q9UHF0 | TAC3 | Tachykinin-3 | Tier 1 | 0.63 | 1 | A_assoc | 2 | 64.88 | 1 | 0 | 0 | 0 | 0 | hypogonadotropic hypogonadism 10 with or without anosmia | 0.5995324402695232 | |||
| Q15818 | NPTX1 | Neuronal pentraxin-1 | Tier 1.5 | 0.628 | 1 | A_assoc | 1 | 75.75 | 0 | 0 | 0 | 0 | 0 | spinocerebellar ataxia 50 | 0.5937598292127286 | |||
| P07098 | LIPF | Gastric triacylglycerol lipase | Tier 1.5 | 0.626 | 1 | A_assoc | 1 | 89.75 | 0 | 0 | 0 | 0 | 0 | obesity | 0.5864662753480862 | |||
| Q6IBW4 | NCAPH2 | Condensin-2 complex subunit H2 | Tier 1.5 | 0.62 | 1 | A_assoc | 1 | 62.41 | 1 | 0 | 0 | 0 | 0 | cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1 | 0.5674645203025676 | |||
| Q8IU60 | DCP2 | m7GpppN-mRNA hydrolase | Tier 1 | 0.613 | 1 | A_assoc | 33 | 66.81 | 0 | 0 | 0 | 0 | 0 | neurodegenerative disease | 0.5442061583114092 | |||
| O00175 | CCL24 | C-C motif chemokine 24 | Tier 1.5 | 0.613 | 1 | A_assoc | 2 | 82.12 | 0 | 0 | 0 | 0 | 0 | Iron deficiency anemia | 0.5428194908352497 | |||
| Q4VCS5 | AMOT | Angiomotin | Tier 1 | 0.608 | 1 | A_assoc | 18 | 56.75 | 0 | 0 | 0 | 0 | 0 | neurodegenerative disease | 0.5261379875719714 | |||
| Q6IQ23 | PLEKHA7 | Pleckstrin homology domain-containing family A member 7 | Tier 1 | 0.599 | 1 | A_assoc | 3 | 56.69 | 0 | 0 | 0 | 0 | 0 | open-angle glaucoma | 0.49623877592982996 | |||
| Q8NI35 | PATJ | InaD-like protein | Tier 1 | 0.596 | 1 | A_assoc | 10 | 60.97 | 0 | 0 | 0 | 0 | 0 | Abnormality of the skeletal system | 0.4853816860727928 | |||
| P15085 | CPA1 | Carboxypeptidase A1 | Tier 1 | 0.594 | 1 | A_assoc | 6 | 95.19 | 0 | 0 | 0 | 0 | 0 | type 2 diabetes mellitus | 0.480064090634254 | |||
| Q9ULL8 | SHROOM4 | Protein Shroom4 | Tier 1.5 | 0.593 | 1 | A_assoc | 1 | 47.09 | 0 | 0 | 0 | 0 | 0 | X-linked intellectual disability, Stocco dos Santos type | 0.4759334640315342 | |||
| Q9Y5W5 | WIF1 | Wnt inhibitory factor 1 | Tier 1 | 0.585 | 1 | A_assoc | 5 | 79.62 | 0 | 0 | 0 | 0 | 0 | hair color | 0.4484184681607677 | |||
| P28039 | AOAH | Acyloxyacyl hydrolase | Tier 1.5 | 0.585 | 1 | A_assoc | 2 | 90.38 | 0 | 0 | 0 | 0 | 0 | type 2 diabetes mellitus | 0.4486206035972812 | |||
| P11684 | SCGB1A1 | Uteroglobin | Tier 1.5 | 0.581 | 1 | A_assoc | 2 | 88.56 | 0 | 0 | 0 | 0 | 0 | chronic obstructive pulmonary disease | 0.43588476688573263 | |||
| Q9UJJ7 | RPUSD1 | RNA pseudouridylate synthase domain-containing protein 1 | Tier 1 | 0.577 | 1 | A_assoc | 1 | 86.5 | 0 | 0 | 0 | 0 | 0 | neurodegenerative disease | 0.4227872470118794 | |||
| Q9Y2H5 | PLEKHA6 | Pleckstrin homology domain-containing family A member 6 | Tier 1 | 0.576 | 1 | A_assoc | 2 | 56.44 | 0 | 0 | 0 | 0 | 0 | diverticular disease | 0.42018657977785967 | |||
| Q63HQ2 | EGFLAM | Pikachurin | Tier 1.5 | 0.574 | 1 | A_assoc | 3 | 80.56 | 1 | 0 | 0 | 0 | 0 | mathematical ability | 0.41387833248094535 | |||
| Q86UU9 | TAC4 | Tachykinin-4 | Tier 1 | 0.572 | 1 | A_assoc | 1 | 56.22 | 0 | 0 | 0 | 0 | 0 | COVID-19 | 0.40729589199586963 | |||
| Q13007 | IL24 | Interleukin-24 | Tier 1.5 | 0.572 | 1 | A_assoc | 2 | 83.38 | 0 | 0 | 0 | 0 | 0 | clear cell renal carcinoma | 0.4074364261926763 | |||
| Q96A83 | COL26A1 | Collagen alpha-1(XXVI) chain | Tier 1.5 | 0.568 | 1 | A_assoc | 6 | 59.66 | 0 | 0 | 0 | 0 | 0 | Inguinal hernia | 0.39338285604421097 | |||
| Q9UNH6 | SNX7 | Sorting nexin-7 | Tier 1.5 | 0.567 | 1 | A_assoc | 1 | 85.81 | 0 | 0 | 0 | 0 | 0 | mathematical ability | 0.3890274527063968 | |||
| P20783 | NTF3 | Neurotrophin-3 | Tier 1.5 | 0.565 | 1 | A_assoc | 5 | 73.75 | 0 | 0 | 0 | 0 | 0 | cancer | 0.3844129381329447 | |||
| P32881 | IFNA8 | Interferon alpha-8 | Tier 1.5 | 0.563 | 1 | A_assoc | 1 | 84.62 | 0 | 0 | 0 | 0 | 0 | renal cell carcinoma | 0.375708720608223 | |||
| Q17R31 | TATDN3 | Deoxyribonuclease TATDN3 | Tier 1 | 0.562 | 1 | A_assoc | 1 | 96.19 | 0 | 0 | 0 | 0 | 0 | neurodegenerative disease | 0.373369201808849 | |||
| P06850 | CRH | Corticoliberin | Tier 1 | 0.562 | 1 | A_assoc | 5 | 61.97 | 1 | 0 | 0 | 0 | 0 | autosomal dominant nocturnal frontal lobe epilepsy | 0.37224647599732263 | |||
| Q9UM21 | MGAT4A | Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A | Tier 1.5 | 0.561 | 1 | A_assoc | 1 | 85.25 | 0 | 0 | 0 | 0 | 0 | COVID-19 | 0.37050380432141355 | |||
| Q7L8A9 | VASH1 | Tubulinyl-Tyr carboxypeptidase 1 | Tier 1 | 0.559 | 1 | A_assoc | 14 | 78.25 | 1 | 0 | 0 | 0 | 0 | Abnormality of the skeletal system | 0.36366533692746233 | |||
| P18509 | ADCYAP1 | Pituitary adenylate cyclase-activating polypeptide | Tier 1 | 0.559 | 1 | A_assoc | 12 | 62.56 | 1 | 0 | 0 | 0 | 0 | alcohol drinking | 0.36407172744864225 | |||
| Q8NBI3 | DRAXIN | Draxin | Tier 1.5 | 0.558 | 1 | A_assoc | 1 | 58.47 | 0 | 0 | 0 | 0 | 0 | neurodegenerative disease | 0.3590692945691625 |
Advanced export
JSON shape: default, array, newline-delimited
CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
-- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
-- Transparent weights over harvested evidence: structure 0.35, disease importance
-- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
-- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
-- are predictions/detections, NOT measured EV-surface exposure.
ROUND(
0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
+ 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
+ 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
+ 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
, 3) AS evidence_priority,
(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
sc.surface_class,
f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;